212 related articles for article (PubMed ID: 12466995)
1. [Barrett metaplasia: how dangerous is it really?].
Stolte M; Vieth M
Z Gastroenterol; 2002 Dec; 40 Suppl 2():5-8. PubMed ID: 12466995
[No Abstract] [Full Text] [Related]
2. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
Shaheen NJ; Spechler SJ
Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
[No Abstract] [Full Text] [Related]
3. [Pathogenesis and epidemiology of Barrett esophagus].
Spechler SJ
Chirurg; 1994 Feb; 65(2):84-7. PubMed ID: 8162820
[No Abstract] [Full Text] [Related]
4. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
[TBL] [Abstract][Full Text] [Related]
6. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
Ell C
Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
[No Abstract] [Full Text] [Related]
7. [Barrett esophagus and Barrett carcinoma].
Kruyt PH; van Sandick JW; van Lanschot JJ; Offerhaus GJ; Tytgat GN; Obertop H
Ned Tijdschr Geneeskd; 1997 May; 141(18):869-73. PubMed ID: 9273450
[TBL] [Abstract][Full Text] [Related]
8. Adiposity and columnar-lined esophagus.
Lenglinger J; Eisler M; Riegler FM
Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
[No Abstract] [Full Text] [Related]
9. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
10. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
Schilling D; Riemann JF
MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
[No Abstract] [Full Text] [Related]
11. Gastroesophageal reflux disease and Barrett's esophagus.
Anand O; Wani S; Sharma P
Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
[No Abstract] [Full Text] [Related]
12. [Topic Complex VI: Barrett esophagus].
Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
[No Abstract] [Full Text] [Related]
13. [Barrett's esophageal adenocarcinoma].
Nakamura T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):322-6. PubMed ID: 15045933
[TBL] [Abstract][Full Text] [Related]
14. Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus.
Tanaka K; Toyoda H; Kadowaki S; Hamada Y; Kosaka R; Yamanaka M; Imoto I
Endoscopy; 2007 Feb; 39 Suppl 1():E105-6. PubMed ID: 17440852
[No Abstract] [Full Text] [Related]
15. The future of endoscopic treatment of early Barrett neoplasia: the endoscopist's view.
Falk GW
Endoscopy; 2008 Dec; 40(12):1041-7. PubMed ID: 19065489
[No Abstract] [Full Text] [Related]
16. [Chronic reflux esophagitis with endobrachyesophagus and multifocal adenocarcinoma].
Lange U; Peek A; Bähr R; Frenzel H
Leber Magen Darm; 1992 May; 22(3):121-4. PubMed ID: 1625510
[TBL] [Abstract][Full Text] [Related]
17. Targeting surveillance in Barrett's esophagus.
Hillman L
J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
[No Abstract] [Full Text] [Related]
18. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
Vieth M; Schubert B; Lang-Schwarz K; Stolte M
Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
[TBL] [Abstract][Full Text] [Related]
19. Magnified view of adenocarcinoma in short segment Barrett's esophagus treated by endoscopic mucosal resection.
Yagi K; Nakamura A; Sekine A; Tamiya Y; Oyamatsu M
Gastrointest Endosc; 2002 Feb; 55(2):278-81. PubMed ID: 11818942
[No Abstract] [Full Text] [Related]
20. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
